GLP1-RAs: A Psychiatric Update
David Liebers, MD. Research Psychiatrist, Nathan Kline Institute for Psychiatric Research; Research Assistant Professor of Psychiatry, NYU Grossman School of Medicine.
Dr. Liebers reports he is principal investigator for Autobahn Therapeutics. Relevant financial relationships listed for the author have been mitigated. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship.



_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747)



